HuGE Literature Finder
Records 1-5
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.
Hereditary cancer in clinical practice 2009 7 (1): 4. Ruijs Marielle W G, Broeks Annegien, Menko Fred H, Ausems Margreet G E M, Wagner Anja, Oldenburg Rogier, Meijers-Heijboer Hanne, van't Veer Laura J, Verhoef Sen |
|
TP53 and CHEK2 *1100delC gene mutation in North American families suggestive Li-Fraumeni syndrome: Memorial Sloan-Kettering experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Jul 22 (14_suppl): 9537. Siddiqui R, Robles Diaz L, Nafa K, Kauff N, Facio F, Huang H, Onel K, Robson M, Ellis N, Offit |
|
CHEK2 1100delC is not a risk factor for male breast cancer population.
International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli |
|
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma.
Cancer letters 2003 Oct 200 (2): 149-52. Lipton Lara, Fleischmann Christina, Sieber Oliver M, Thomas Huw J W, Hodgson Shirley V, Tomlinson Ian P M, Houlston Richard |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jul 01, 2020
- Content source: